• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国放射学会(ACR)胰腺导管腺癌分期适宜性标准

ACR Appropriateness Criteria Staging of Pancreatic Ductal Adenocarcinoma.

作者信息

Qayyum Aliya, Tamm Eric P, Kamel Ihab R, Allen Peter J, Arif-Tiwari Hina, Chernyak Victoria, Gonda Tamas A, Grajo Joseph R, Hindman Nicole M, Horowitz Jeanne M, Kaur Harmeet, McNamara Michelle M, Noto Richard B, Srivastava Pavan K, Lalani Tasneem

机构信息

Principal Author, University of Texas MD Anderson Cancer Center, Houston, Texas.

Research Author, University of Texas MD Anderson Cancer Center, Houston, Texas.

出版信息

J Am Coll Radiol. 2017 Nov;14(11S):S560-S569. doi: 10.1016/j.jacr.2017.08.050.

DOI:10.1016/j.jacr.2017.08.050
PMID:29101993
Abstract

Pancreatic adenocarcinoma is associated with poor overall prognosis. Complete surgical resection is the only possible option for cure. As such, increasingly complex surgical techniques including sophisticated vascular reconstruction are being used. Continued advances in surgical techniques, in conjunction with use of combination systemic therapies, and radiation therapy have been suggested to improve outcomes. A key aspect to surgical success is reporting of pivotal findings beyond absence of distant metastases, such as tumor size, location, and degree of tumor involvement of specific vessels associated with potential perineural tumor spread. Multiphase contrast-enhanced multidetector CT and MRI are the imaging modalities of choice for pretreatment staging and presurgical determination of resectability. Imaging modalities such as endoscopic ultrasound and fluorine-18-2-fluoro-2-deoxy-D-glucose imaging with PET/CT are indicated for specific scenarios such as biopsy guidance and confirmation of distant metastases, respectively. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.

摘要

胰腺腺癌的总体预后较差。完整的手术切除是唯一可能的治愈选择。因此,越来越复杂的手术技术,包括精密的血管重建技术正在被应用。手术技术的持续进步,结合全身联合治疗和放射治疗,被认为可以改善治疗效果。手术成功的一个关键方面是报告除无远处转移之外的关键发现,例如肿瘤大小、位置以及与潜在神经周围肿瘤扩散相关的特定血管的肿瘤累及程度。多期对比增强多层螺旋CT和MRI是术前分期及术前判断可切除性的首选成像方式。诸如内镜超声和PET/CT氟代脱氧葡萄糖成像等成像方式分别适用于活检引导和远处转移确认等特定情况。美国放射学会适宜性标准是针对特定临床情况的循证指南,每年由多学科专家小组进行审查。指南的制定和修订包括对同行评审期刊上的当前医学文献进行广泛分析,并应用成熟的方法(兰德/加州大学洛杉矶分校适宜性方法以及推荐评估、制定和评价分级系统或GRADE)来评估特定临床情况下成像和治疗程序的适宜性。在缺乏证据或证据不明确的情况下,专家意见可补充现有证据以推荐成像或治疗方法。

相似文献

1
ACR Appropriateness Criteria Staging of Pancreatic Ductal Adenocarcinoma.美国放射学会(ACR)胰腺导管腺癌分期适宜性标准
J Am Coll Radiol. 2017 Nov;14(11S):S560-S569. doi: 10.1016/j.jacr.2017.08.050.
2
Patient-Friendly Summary of the ACR Appropriateness Criteria: Staging of Pancreatic Ductal Adenocarcinoma.美国放射学会适宜性标准患者友好摘要:胰腺导管腺癌的分期
J Am Coll Radiol. 2019 Apr;16(4 Pt A):e15. doi: 10.1016/j.jacr.2018.12.013.
3
ACR Appropriateness Criteria Suspected Liver Metastases.ACR 适宜性标准:疑似肝转移。
J Am Coll Radiol. 2017 May;14(5S):S314-S325. doi: 10.1016/j.jacr.2017.01.037.
4
ACR Appropriateness Criteria Staging and Follow-Up of Ovarian Cancer.ACR 适宜性标准:卵巢癌的分期和随访。
J Am Coll Radiol. 2018 May;15(5S):S198-S207. doi: 10.1016/j.jacr.2018.03.015.
5
ACR Appropriateness Criteria Pretreatment Staging of Muscle-Invasive Bladder Cancer.ACR 适宜性标准——肌肉浸润性膀胱癌的术前分期。
J Am Coll Radiol. 2018 May;15(5S):S150-S159. doi: 10.1016/j.jacr.2018.03.020.
6
ACR Appropriateness Criteria Pretreatment Staging of Colorectal Cancer.ACR 适宜性标准:结直肠癌治疗前分期。
J Am Coll Radiol. 2017 May;14(5S):S234-S244. doi: 10.1016/j.jacr.2017.02.012.
7
ACR Appropriateness Criteria Cranial Neuropathy.美国放射学会(ACR)适宜性标准:颅神经病变
J Am Coll Radiol. 2017 Nov;14(11S):S406-S420. doi: 10.1016/j.jacr.2017.08.035.
8
ACR Appropriateness Criteria Monitoring Response to Neoadjuvant Systemic Therapy for Breast Cancer.美国放射学会(ACR)乳腺癌新辅助全身治疗监测反应适宜性标准
J Am Coll Radiol. 2017 Nov;14(11S):S462-S475. doi: 10.1016/j.jacr.2017.08.037.
9
ACR Appropriateness Criteria Chronic Liver Disease.美国放射学会适宜性标准:慢性肝病
J Am Coll Radiol. 2017 Nov;14(11S):S391-S405. doi: 10.1016/j.jacr.2017.08.045.
10
ACR Appropriateness Criteria Iliac Artery Occlusive Disease.美国放射学会(ACR)髂动脉闭塞性疾病适宜性标准
J Am Coll Radiol. 2017 Nov;14(11S):S530-S539. doi: 10.1016/j.jacr.2017.08.039.

引用本文的文献

1
Diagnostic value of endoscopic ultrasound in staging of pancreatic cancer.内镜超声在胰腺癌分期中的诊断价值。
World J Gastrointest Oncol. 2025 Jul 15;17(7):107670. doi: 10.4251/wjgo.v17.i7.107670.
2
Performance of fibroblast activating protein inhibitor PET imaging for pancreatic neoplasms assessment: a systematic review and meta-analysis.成纤维细胞激活蛋白抑制剂 PET 成像在胰腺肿瘤评估中的性能:系统评价和荟萃分析。
Eur Radiol. 2024 Dec;34(12):7804-7812. doi: 10.1007/s00330-024-10843-z. Epub 2024 Jun 21.
3
Imaging of pancreatic ductal adenocarcinoma - An update for all stages of patient management.
胰腺导管腺癌的影像学检查——患者管理各阶段的最新进展
Eur J Radiol Open. 2024 Feb 8;12:100553. doi: 10.1016/j.ejro.2024.100553. eCollection 2024 Jun.
4
A narrative review of imaging for pancreas adenocarcinoma: staging, surgical considerations, and surveillance.胰腺腺癌影像学检查的叙述性综述:分期、手术考量及监测
J Gastrointest Oncol. 2023 Oct 31;14(5):2260-2272. doi: 10.21037/jgo-22-1044. Epub 2023 Sep 21.
5
Advances in pre-treatment evaluation of pancreatic ductal adenocarcinoma: a narrative review.胰腺导管腺癌的预处理评估进展:一篇叙述性综述。
J Gastrointest Oncol. 2023 Apr 29;14(2):1114-1130. doi: 10.21037/jgo-22-1034. Epub 2023 Mar 29.
6
Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer.用于检测早期胰腺癌的小体积样本中的血浆 miRNA 生物标志物。
Cancer Prev Res (Phila). 2021 Jul;14(7):729-740. doi: 10.1158/1940-6207.CAPR-20-0303. Epub 2021 Apr 23.
7
The Role of Endoscopic Ultrasound in Pancreatic Cancer Staging in the Era of Neoadjuvant Therapy and Personalised Medicine.内镜超声在新辅助治疗和个性化医疗时代胰腺癌分期中的作用
GE Port J Gastroenterol. 2021 Feb;28(2):111-120. doi: 10.1159/000509197. Epub 2020 Sep 7.
8
Impact of Ga-FAPI PET/CT Imaging on the Therapeutic Management of Primary and Recurrent Pancreatic Ductal Adenocarcinomas.Ga-FAPI PET/CT 成像对原发性和复发性胰腺导管腺癌治疗管理的影响。
J Nucl Med. 2021 Jun 1;62(6):779-786. doi: 10.2967/jnumed.120.253062. Epub 2020 Oct 23.
9
Imaging diagnosis and staging of pancreatic ductal adenocarcinoma: a comprehensive review.胰腺导管腺癌的影像学诊断与分期:综述
Insights Imaging. 2020 Apr 25;11(1):58. doi: 10.1186/s13244-020-00861-y.